Annual report
7129.TEDINET S100R6MQ
Period2022-04-01 → 2023-03-31
Filed2023-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks22 of 22 passed
Key figures · 74
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥19.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥191m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥186m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥169m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥190m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥348m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥534m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥210m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥292m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥210m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥292m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥14.1bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥14.2bn | at 2022-03-31 | Cons. | Assets |
| Total liabilities | ¥10.8bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥11.0bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.2bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.0bn | at 2021-03-31d | Cons. | Net assets |
| Cash and deposits | ¥1.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥691m | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥919m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥557m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥369m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥84.22 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥117.49 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥83.84 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥116.61 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,341.2 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,287.13 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 23.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.5% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.4% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.4% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,782 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 1,752 | at 2022-03-31 | Cons. | Number of employees |
| Revenue | ¥278m | 2022-04-01 → 2023-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥116m | 2021-04-01 → 2022-03-31 | Standalone | Operating revenue1 |
| Operating income | ¥85m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥52m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥90m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥52m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Profit before tax | ¥90m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥52m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥60m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥62m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Total assets | ¥3.2bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥3.1bn | at 2022-03-31 | Standalone | Assets |
| Total liabilities | ¥141m | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥71m | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.1bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.1bn | at 2022-03-31 | Standalone | Net assets |
| Cash and deposits | ¥32m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥3m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥24.16 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.86 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥24.06 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥24.68 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥30 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥17 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,226.96 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,232.94 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 95.6% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 97.7% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 2.0% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.0% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,488,700 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,488,300 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 92
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2022-04-01 → 2023-03-31 | ¥540,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2023-03-31 | 21 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥974m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥945m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥29m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-03-31 | ¥180m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2023-03-31 | ¥48m |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥13m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥43m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥29m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥29m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥2.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥778m |
| Medicine Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥103m |
| Medicine Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥88m |
| Medicine Businessreportable segment | employees | at 2023-03-31 | 199 pure |
| Medicine Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥9.0bn |
| Medicine Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥9.0bn |
| Medicine Businessreportable segment | segment assets | at 2023-03-31 | ¥2.9bn |
| Medicine Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥531m |
| Nursing Care Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥8m |
| Nursing Care Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥45m |
| Nursing Care Businessreportable segment | employees | at 2023-03-31 | 296 pure |
| Nursing Care Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥3.4bn |
| Nursing Care Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥3.4bn |
| Nursing Care Businessreportable segment | segment assets | at 2023-03-31 | ¥1.1bn |
| Nursing Care Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥147m |
| Nurturing Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥515m |
| Nurturing Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥400m |
| Nurturing Businessreportable segment | employees | at 2023-03-31 | 1219 pure |
| Nurturing Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥8.9bn |
| Nurturing Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥8.9bn |
| Nurturing Businessreportable segment | segment assets | at 2023-03-31 | ¥7.8bn |
| Nurturing Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥537m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥626m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥533m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥21.3bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥21.3bn |
| —segment total | segment assets | at 2023-03-31 | ¥11.9bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥921m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥626m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥536m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥22.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥22.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥29m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥12.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥970m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-04-01 → 2022-03-31 | ¥237,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥932m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥905m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥27m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-03-31 | ¥165m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | ¥39m |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥218m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥42m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥27m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥27m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥2.0bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥798m |
| Medicine Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥175m |
| Medicine Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥68m |
| Medicine Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥8.8bn |
| Medicine Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥8.8bn |
| Medicine Businessreportable segment | segment assets | at 2022-03-31 | ¥2.9bn |
| Medicine Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥559m |
| Nursing Care Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥69m |
| Nursing Care Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥55m |
| Nursing Care Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥3.4bn |
| Nursing Care Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥3.4bn |
| Nursing Care Businessreportable segment | segment assets | at 2022-03-31 | ¥1.2bn |
| Nursing Care Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥25m |
| Nurturing Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥2.6bn |
| Nurturing Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥307m |
| Nurturing Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥6.4bn |
| Nurturing Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥6.4bn |
| Nurturing Businessreportable segment | segment assets | at 2022-03-31 | ¥7.8bn |
| Nurturing Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥362m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥430m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥18.6bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥18.6bn |
| —segment total | segment assets | at 2022-03-31 | ¥12.0bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥946m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥434m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥19.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥19.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥27m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥12.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥985m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,258
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and cash equivalents (5-year summary) | CurrentYearInstant | 1182721000 | JPY |
| Number of employees | Prior1YearInstant | 1752 | |
| Number of employees | CurrentYearInstant | 1782 | |
| Average number of temporary workers | Prior1YearInstant | 813 | |
| Average number of temporary workers | CurrentYearInstant | 811 | |
| Operating revenue1 (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 115850000 | JPY |
| Operating revenue1 (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 277782000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 52062000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 90275000 | JPY |
| Net income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 61704000 | JPY |
| Net income loss (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 60132000 | JPY |
| Capital stock (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 300550000 | JPY |
| Capital stock (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 300620000 | JPY |
| Total number of issued shares (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 2488300 | |
| Total number of issued shares (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 2488700 | |
| Net assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 3067865000 | JPY |
| Net assets (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 3053448000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 3138611000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 3194712000 | JPY |
| Net assets per share (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 1232.94 | |
| Net assets per share (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 1226.96 | |
| Dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 17.00 | |
| Dividend paid per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 30.00 | |
| Interim dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Interim dividend paid per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 13.00 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 24.86 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 24.16 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 24.68 | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 24.06 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 0.977 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 0.956 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 0.020 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 0.020 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 40.5 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 41.9 | |
| Payout ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 0.684 | |
| Payout ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 1.242 | |
| Number of employees | Prior1YearInstant_NonConsolidatedMember | － | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | － | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | － | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | － | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | － | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 1.0581 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | － | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 33.2474 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E36714-000MedicineBusinessReportableSegmentMember | 199 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E36714-000MedicineBusinessReportableSegmentMember | 72 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E36714-000NursingCareBusinessReportableSegmentMember | 296 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E36714-000NursingCareBusinessReportableSegmentMember | 252 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E36714-000NurturingBusinessReportableSegmentMember | 1219 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 22 of 22 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |